|
Match
|
Document |
Document Title |
|
|
US20150053201 |
NASAL ADMINISTRATION
A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for... |
|
|
US20130133643 |
Inhalation Device
An actuator for an inhaler for delivering medicament by inhalation, comprising: a main body comprising a tubular member for receiving a canister containing medicament and having a valve stem... |
|
|
US20110251157 |
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can... |
|
|
US20110005518 |
METHODS AND UNIT DOSE FORMULATIONS FOR THE INHALATION ADMINISTRATION OF AMINOGLYCOSIDE ANTIBIOTICS
A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from... |
|
|
US20080223363 |
Nasal Delivery Devices
An exhalation breath-actuated nasal delivery device for and a method of delivering a substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece (40) for fitting to a... |
|
|
US20080175887 |
Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic... |
|
|
US20080017191 |
Metered dose inhaler
A medicinal aerosol product comprising a pressurized metered dose inhaler, including a canister equipped with a metering valve and containing a medicinal aerosol solution formulation, and an... |
|
|
US20080017189 |
Breath actuated inhaler
A breath actuated metered dose inhaler including a housing, a mouthpiece positioned at one end of the housing, and a mechanical release mechanism positioned at another end of the housing. The... |
|
|
US20070175469 |
DISPENSING DEVICE
A dispensing device dispenses a liquid, in particular containing or formed of a drug, as a fine spray, that has a high fraction of small particles achieved by using a duct or slit having a flat... |
|
|
US20050145253 |
Bronchial flow control devices and methods of use
Methods and systems for lung volume reduction of a patient are described. The methods include implanting a flow control device in a bronchial passageway of the lung. The flow control device... |
|
|
US20050142071 |
Pressurised metered dose inhalers (MDI)
The invention relates to the use of pressurised metered dose inhalers (MDIs) having part or all of their internal surfaces consisting of stainless steel, anodised aluminium or lined with an inert... |
|
|
US20150165137 |
INHALATION DEVICE FOR USE IN AEROSOL THERAPY
An inhalation device having a base unit, a mouthpiece, and an aerosol head is provided. The base unit has an air inlet, an air outlet opening, a groove for receiving the mouthpiece, and key lock... |
|
|
US20150150803 |
AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
An aerosol preparation assembly includes an entrainment chamber defining an entrainment volume. The entrainment chamber includes a gas inlet port, an aerosol inlet port and an outlet port. The... |
|
|
US20140363384 |
COMBINATION THERAPY FOR COPD
Aerosol formulations comprising glycopyrronium chloride in combination with formoterol may be administered by means of a pressurized metered dose inhaler (pMDI) for the prevention or treatment of... |
|
|
US20130074834 |
Pharmaceutical Combinations
A pharmaceutical combination comprising (a) a combination of two or more bronchodilators; or (b) a combination of at least one bronchodilator in combination with at least one corticosteroid. |
|
|
US20110150784 |
COMBINATION THERAPY FOR COPD
Aerosol formulations comprising glycopyrronium chloride in combination with formoterol may be administered by means of a pressurized metered dose inhaler (pMDI) for the prevention or treatment of... |
|
|
US20110100361 |
PRESSURISED METERED DOSE INHALERS (MDI)
The invention relates to pressurized metered dose inhalers (MDIs) in which all or part of the internal surface is lined with an inert organic coating and which contain a formulation which... |
|
|
US20110000481 |
NEBULIZER FOR INFANTS AND RESPIRATORY COMPROMISED PATIENTS
A pediatric nebulizer is described. |
|
|
US20100307487 |
RESPIRATORY THERAPY DEVICE AND METHOD
A respiratory therapy device including a housing and an interrupter valve assembly. The housing includes a patient inlet, an exhaust outlet, a chamber, and a supply inlet. The interrupter valve... |
|
|
US20090188491 |
Medicaments
This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises particulate salbutamol... |
|
|
US20090110679 |
Methods and compositions for pulmonary administration of a TNFa inhibitor
The invention describes methods of pulmonary delivery of a TNFα inhibitor to a subject having a disorder in which TNFα is detrimental, such that the disorder is treated. Also included is a method... |
|
|
US20090025713 |
Nebulised Antibiotics for Inhalation Therapy
The present invention provides pharmaceutical aerosols which are useful for the prevention or treatment of infectious diseases of the airways, such as the lungs, the bronchi, or the sinunasal... |
|
|
US20080099011 |
INHALED INSULIN DOSAGE CONTROL DELIVERY ENHANCED BY CONTROLLING TOTAL INHALED VOLUME
Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total... |
|
|
US20070154407 |
INHALER AND STORE FOR A DRY MEDICAMENT FORMULATION AND RELATED METHODS AND USE THEREOF
An inhaler, a store and a method for atomizing a dry medicament formulation are disclosed. The medicament formulation is first dissolved by a liquid solvent and then atomized together with the... |
|
|
US20070104655 |
Inhalable tiotropium and container therefor
A medical product suitable for storing and delivering a pre-metered dose of tiotropium, devices containing the same, and methods of using the same. |
|
|
US20060257327 |
Medical product
The invention discloses a medical product for use in a treatment of respiratory disorders, and comprises a metered dose of a tiotropium dry powder formulation, directly loaded and sealed into a... |
|
|
US20060254581 |
Dose counting in metered dose inhaler
A counter for indicating the number of doses left in a canister that is suitable for use in a metered dose inhaler. The counter is affixed to the canister and includes a module for providing an... |
|
|
US20060083693 |
Stable pharmaceutical solution formulations for pressurised metered dose inhalers
An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to... |
|
|
US20060078506 |
Methods, systems and devices for noninvasive pulmonary delivery
The invention is directed to noninvasive methods, systems and devices for pulmonary delivery of aerosolized active agents and methods of treating respiratory dysfunction. |
|
|
US20050220717 |
Steroid solution aerosol products with enhanced chemical stability
A medicinal aerosol steroid solution formulation product with enhanced chemical stability. The steroid is a 20-ketosteroid having an OH group at the C-17 or C-21 position and the aerosol container... |
|
|
US20050147565 |
Pharmaceutical compositions for the treatment of asthma
Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and formoterol fumarate and processes for preparing the same. |
|
|
US20050126562 |
Treatment of breakthrough pain by drug aerosol inhalation
Devices comprising a housing defining an airway, at least one support configured to couple to the airway comprising at least one area selected from a first area and a second area, wherein a first... |
|
|
US20050056275 |
Systems and methods for powder from receptacles
A method for aerosolizing a powder utilizes a receptacle having a cavity containing a powder. An access end of an extraction tube is inserted into the cavity, and an inlet opening is formed in the... |
|
|
US20150182459 |
STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or... |
|
|
US20150133456 |
FLUOROERGOLINE DERIVATIVES AND USES THEREOF
Provided herein are novel fluoroergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical... |
|
|
US20140170220 |
MULTIMODAL PARTICULATE FORMULATIONS
Multimodal particulate formulations of medicaments and methods for their use, e.g. by nasal or pulmonary administration for the treatment of various medical conditions, are provided. |
|
|
US20100212665 |
ACTUATOR NOZZLE FOR METERED DOSE INHALER
An actuator for a metered dose inhaler containing a liquefied propellant and a medicament, the actuator comprising: a nozzle block having a fluid flow path extending therethrough, the fluid flow... |
|
|
US20100180888 |
Device Housing for an Aerosol Container
A housing for a mechanical or electrical device for use with an aerosol canister for containing chemical comprising a sleeve for receipt of the aerosol canister, a collar affixable around the neck... |
|
|
US20090041682 |
MEDICAL PRODUCT
The invention discloses a medical product for use in a treatment of respiratory disorders, and comprises a metered dose of a tiotropium dry powder formulation, directly loaded and sealed into a... |
|
|
US20080041369 |
AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS
The present invention relates to a propellant-free aerosol formulation which contains one or more compounds of general formula 1, wherein the groups R1, R2, R3 and X− may have the meanings... |
|
|
US20050186142 |
Kit and composition of imidazole with enhanced bioavailability
A composition and therapeutic kit provide a therapeutic azole with increased solubility. The kit includes an aerosol packaging assembly containing a container accommodating a pressurized product... |
|
|
US20160193432 |
DRUG DELIVERY DEVICE
Drug delivery devices are described that include sensors and processing circuitry that can detect operating events, such as flow rates and drug delivery, in various types of inhalers, such as dry... |
|
|
US20140311482 |
Rhinosinusitis Prevention and Therapy with Proinflammatory Cytokine Inhibitors
The disclosure describes an aerosolizer with (i) means sized for intranasal or paranasal insertion that produces an aerosol from a material for delivery in close proximity to the upper airways,... |
|
|
US20050121032 |
Pre-metered dry powder inhaler for moisture-sensitive medicaments
The invention discloses a dry powder inhaler for use in a treatment of respiratory disorders. |
|
|
US20050121027 |
Inhalable tiotropium and container therefor
A medical product suitable for storing and delivering a pre-metered dose of tiotropium, devices containing the same, and methods of using the same. |
|
|
US20160184536 |
AEROSOL MEDICATION INHALATION SYSTEM
An apparatus for use in conjunction with a metered dose inhaler which includes a novel valve system to aid in the delivery of aerosolized medicament to a subject. The apparatus also includes a... |
|
|
US20140179707 |
NOVEL ERGOLINE DERIVATIVES AND USES THEREOF
Provided herein are 8′-Hydroxy-2-CF3-dihydroergotamine (8′OH-2-CF3-DHE) compounds, compositions, and dosage forms containing such compositions. Also provided herein are methods of treatment,... |
|
|
US20110308516 |
Delivery device for a powder aerosol
The invention provides a delivery device (10) for a medicament comprising: a housing (50),a receptacle (54) holding a medicament (80) in the form of a powder; anda source of propellant (53),... |
|
|
US20110132355 |
TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED BETA 2-AGONIST OR COMBINED NEBULIZED BETA 2-AGONIST AND ANTICHOLINERGIC ADMINISTRATION
Inhalation solutions for administration of beta 2-agonists or combinations of muscarinic antagonists and beta 2-agonists for the treatment of breathing disorders, such as COPD, are provided. The... |
|
|
US20080041370 |
AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS
The present invention relates to a propellant-free aerosol formulation which contains one or more compounds of general formula 1, wherein the groups R1, R2, R3 and X− may have the meanings... |